FDA Preamble FR Notices, Vol 71 No 10 CGMP Regulation and Investigational New Drugs, 01/06 2021-09-22T15:11:27+00:00November 20th, 2019|
FDA Preamble FR Notices, Vol 60 No 13 CGMP Amendment of certain requirements for Finished Pharmaceuticals, 1/95 2020-07-30T12:03:59+00:00November 20th, 2019|
FDA Preamble FR Notices, Vol 58 No 80 Retention of Bioavailability and Bioequivalence Testing Samples, 04/93 2021-09-22T15:09:43+00:00November 20th, 2019|
FDA Preamble FR Notices, Vol 63 No 213 Tamper-Evident Packaging Requirements for OTC drug products, 11/98 2021-09-22T15:10:53+00:00November 20th, 2019|
FDA Preamble FR Notices, CGMP Revision of Certain Labeling Controls, 08/93 2020-07-30T13:21:24+00:00November 20th, 2019|